These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 28443468)
21. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy. Hua L; Zhu G; Wei J Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226 [TBL] [Abstract][Full Text] [Related]
22. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer. Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569 [TBL] [Abstract][Full Text] [Related]
23. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094 [TBL] [Abstract][Full Text] [Related]
24. Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor. Li S; Liu Z; Zhu F; Fan X; Wu X; Zhao H; Jiang L Oncol Res; 2013; 21(3):137-44. PubMed ID: 24512728 [TBL] [Abstract][Full Text] [Related]
25. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Chatterjee A; Chattopadhyay D; Chakrabarti G Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430 [TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment. Ma Z; Liu D; Di S; Zhang Z; Li W; Zhang J; Xu L; Guo K; Zhu Y; Li X; Han J; Yan X J Pineal Res; 2019 Sep; 67(2):e12587. PubMed ID: 31090223 [TBL] [Abstract][Full Text] [Related]
27. MTA1 promotes metastasis of MPM via suppression of E-cadherin. Xu C; Hua F; Chen Y; Huang H; Ye W; Yu Y; Shen Z J Exp Clin Cancer Res; 2015 Dec; 34():151. PubMed ID: 26689197 [TBL] [Abstract][Full Text] [Related]
28. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Jin H; Qiao F; Wang Y; Xu Y; Shang Y Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877 [TBL] [Abstract][Full Text] [Related]
29. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma. Wang G; Wang S; Li C Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568 [TBL] [Abstract][Full Text] [Related]
30. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC). Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074 [TBL] [Abstract][Full Text] [Related]
31. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing. Hu S; Yuan Y; Song Z; Yan D; Kong X Cell Physiol Biochem; 2018; 51(6):2509-2522. PubMed ID: 30557872 [TBL] [Abstract][Full Text] [Related]
32. High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer. Yu J; Zhou J; Xu F; Bai W; Zhang W Int J Biol Markers; 2018 May; 33(2):215-221. PubMed ID: 29707994 [TBL] [Abstract][Full Text] [Related]
33. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins. Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089 [TBL] [Abstract][Full Text] [Related]
34. Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel. Chen K; Shi W Tumour Biol; 2016 Aug; 37(8):10539-44. PubMed ID: 26852748 [TBL] [Abstract][Full Text] [Related]
35. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer. Zhu X; Guo Y; Li X; Ding Y; Chen L J Thorac Oncol; 2010 Aug; 5(8):1159-66. PubMed ID: 20661085 [TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer. Liu C; Lv D; Li M; Zhang X; Sun G; Bai Y; Chang D Int J Oncol; 2017 Jun; 50(6):2079-2090. PubMed ID: 28440397 [TBL] [Abstract][Full Text] [Related]
37. Expression of the MTA1 mRNA in advanced lung cancer. Sasaki H; Moriyama S; Nakashima Y; Kobayashi Y; Yukiue H; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y Lung Cancer; 2002 Feb; 35(2):149-54. PubMed ID: 11804687 [TBL] [Abstract][Full Text] [Related]
38. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer. Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799 [TBL] [Abstract][Full Text] [Related]
39. Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression. Mao K; Liu F; Liu X; Khuri FR; Marcus AI; Li M; Zhou W Lung Cancer; 2015 May; 88(2):131-8. PubMed ID: 25769882 [TBL] [Abstract][Full Text] [Related]
40. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR. Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]